PRIM&R has long prided itself on its role as a convener of divergent opinions and viewpoints. One of the ways we fulfill this role is through the development and nurturing of a diverse membership community, hailing from all parts of the research enterprise, from institutions large and small, public and private, from across the country and around the world. Read more
TAG ARCHIVES FOR clinical trials
This week’s Research Ethics Roundup covers President Trump’s call for removing a majority of FDA regulations, the argument for calling for efficacy data before human research begins, USDA’s decision to remove Animal Welfare Act records, and FDA’s case for conducting phase three testing. Read more
This week’s Research Ethics Roundup explores ClinicalTrials.gov transparency issues, a potentially controversial citywide study of a new procedure for gunshot and stabbing victims in Philadelphia, charges against an Indian drug developer accused of fraudulent research, and a rebuttal to researchers who have resisted including female mice and rats in pain research. Read more
Webinar Follow-Up: Addressing the Challenge of Simultaneous and Sequential Study EnrollmentTags:
On April 13, 2016, PRIM&R hosted a webinar titled Familiar Faces: Addressing the Challenge of Simultaneous and Sequential Study Enrollment, presented by Stephanie Collins Reed, PhD, CIP and Ilene Wilets, PhD, CIP.
This webinar defined and estimated the prevalence of simultaneous and sequential study enrollment across the research enterprise, discussed best practices for IRBs and investigators, and provided considerations for policy development. (more…)Read more
This week’s Research Ethics Roundup focuses on the ethical arguments for conducting Zika research on pregnant women, Public Citizen’s challenge of the Food and Drug Administration's (FDA's) redaction policy, and the official investigation on why a phase I trial in France left one dead. (more…) Read more